Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • The role of data and safety monitoring boards in implementation trials: When are they justified?

  • Kevin Fiscella, Mechelle Sanders, Tameir Holder, Jennifer K. Carroll, Amneris Luque, Andrea Cassells, Brent A. Johnson, Stephen K. Williams, Jonathan N. Tobin
  • Journal:
    Journal of Clinical and Translational Science / Volume 4 / Issue 3 / June 2020
    Published online by Cambridge University Press:
    05 March 2020, pp. 229-232
    • Article
      • You have access
      • Open access
    • PDF
    • HTML
    • Export citation

  • The National Institutes of Health requires data and safety monitoring boards (DSMBs) for all phase III clinical trials. The National Heart, Lung and Blood Institute requires DSMBs for all clinical trials involving more than one site and those involving cooperative agreements and contracts. These policies have resulted in the establishment of DSMBs for many implementation trials, with little consideration regarding the appropriateness of DSMBs and/or key adaptations needed by DSMBs to monitor data quality and participant safety. In this perspective, we review the unique features of implementation trials and reflect on key questions regarding the justification for DSMBs and their potential role and monitoring targets within implementation trials.